Scinai Immunotherapeutics Ltd. SCNI
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.52$0.57
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | 0.00% | 67.95% | 67.95% | 0.00% |
| Total Receivables | 0.00% | 0.00% | 20.86% | 20.86% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | 0.00% | -68.22% | -68.22% | 0.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 5.63% | 5.63% | 0.00% |
| Total Current Assets | 0.00% | 0.00% | 36.39% | 36.39% | 0.00% |
|
|
|||||
| Total Current Assets | 0.00% | 0.00% | 36.39% | 36.39% | 0.00% |
| Net Property, Plant & Equipment | 0.00% | 0.00% | -7.37% | -7.37% | 0.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.00% | 0.00% | -1.81% | -1.81% | 0.00% |
|
|
|||||
| Total Accounts Payable | 0.00% | 0.00% | -38.24% | -38.24% | 0.00% |
| Total Accrued Expenses | 0.00% | 0.00% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 0.00% | -33.80% | -33.80% | 0.00% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | -90.66% | -90.66% | 0.00% |
| Total Other Current Liabilities | 0.00% | 0.00% | -90.66% | -90.66% | 0.00% |
| Total Current Liabilities | 0.00% | 0.00% | -25.24% | -25.24% | 0.00% |
|
|
|||||
| Total Current Liabilities | 0.00% | 0.00% | -25.24% | -25.24% | 0.00% |
| Long-Term Debt | 0.00% | 0.00% | 0.34% | 0.34% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | 0.00% | 4.98% | 4.98% | 0.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00% |
| Total Liabilities | 0.00% | 0.00% | -11.53% | -11.53% | 0.00% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 3.52% | 3.52% | 0.00% |
| Retained Earnings | 0.00% | 0.00% | -3.43% | -3.43% | 0.00% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 0.00% | 0.00% | 10.98% | 10.98% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 0.00% | 0.00% | 10.98% | 10.98% | 0.00% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | 0.00% | 3.12% | 3.12% | 0.00% |
|
|
|||||